Dev Labtech Venture Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/04/2025 ,inter alia, to consider and approve INTIMATION OF BOARD MEETING ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dev Labtech Venture Ltd (BSE SME, Scrip Code 543848) has informed BSE that its Board of Directors will meet on Wednesday, 30 April 2025 at 10:00 AM in Surat. The most material agenda item is the consideration and approval of conversion of warrants into equity shares and allotment of those shares to specified persons against balance outstanding amounts. The remaining agenda is largely routine compliance — noting director interest and disqualification declarations, reviewing independent directors' independence and appointment terms, taking note of the Q4 FY25 Investor Grievance Report, reviewing company policies and code of conduct, and authorising filings with the Registrar of Companies. Importantly, the agenda does not include approval of audited or quarterly financial results, even though the meeting falls in the typical results-announcement window.
Existing shareholders should watch the warrant-to-equity conversion closely, as it will increase the company's share count and dilute their holdings. Apart from this dilution risk, the rest of the agenda is standard regulatory housekeeping with no direct earnings or strategic implication.